Current
Neuro-Oncology

Volume 20 Number 2
28 February 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 2, 28 February

Cai X, Qin JJ, Hao SY, Li H, Zeng C, Sun SJ, Yu LB, Gao ZX, Xie J.
Clinical characteristics associated with the intracranial dissemination of gliomas.
Clin Neurol Neurosurg. 2018 Feb 1, 2018;166:141-146→. doi: 10.1016/j.clineuro.2018.01.038→. PMID: 29427894→. Observational study. ˍ

Dias AH, Bouchelouche K.
Prostate-Specific Membrane Antigen PET/CT Incidental Finding of a Schwannoma.
Clin Nucl Med. 2018 Feb 3, 2018;43(4):267-268→. doi: 10.1097/RLU.0000000000001988→. PMID: 29401152→. Case report. ˍ

Granados AM, Zuñiga N, Ospina C, Merchancano L.
Secondary glioblastoma with abdominal metastasis: Case report.
Radiol Case Rep. 2018 Feb 3, 2018;13(2):347-351→. doi: 10.1016/j.radcr.2018.01.004→. PMID: 29904470→. Case report. ˍ

Davies J, Reyes-Rivera I, Pattipaka T, Skirboll S, Ugiliweneza B, Woo S, Boakye M, Abrey L, Garcia J, Burton E.
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States.
Neurooncol Pract. 2018 Feb 6, 2018;5(4):251-261→. doi: 10.1093/nop/npy001→. PMID: 31385957→. Observational study. ˍ

Gurcay AG, Bozkurt I, Senturk S, Kazanci A, Gurcan O, Turkoglu OF, Beskonakli E.
Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy.
Asian J Neurosurg. 2018 Feb 6, 2018;13(1):86-89→. doi: 10.4103/1793-5482.181115? PMID: 29492130→. Case report. ˍ

Albatly AA, Alsamarah AT, Alhawas A, Veit-Haibach P, Buck A, Stolzmann P, Burger IA, Kollias SS, Huellner MW.
Value of ¹⁸F-FET PET in adult brainstem glioma.
Clin Imaging. 2018 Feb 7, 2018;51:68-75→. doi: 10.1016/j.clinimag.2018.01.015→. PMID: 29448122→. Observational study. ˍ

Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, Cañete A, Saran F, Le Deley MC, Varlet P, Morgan PS, Jaspan T, Jones C, Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L, Hargrave D, Vassal G.
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.
J Clin Oncol. 2018 Feb 7, 2018;36(10):951-958→. doi: 10.1200/JCO.2017.76.0611→. PMID: 29412784→. Interventional study. ˍ

Johnston DL, Keene D, Strother D, Taneva M, Lafay-Cousin L, Fryer C, Scheinemann K, Carret AS, Fleming A, Afzal S, Wilson B, Bowes L, Zelcer S, Mpofu C, Silva M, Larouche V, Brossard J, Bouffet E.
Survival Following Tumor Recurrence in Children With Medulloblastoma.
J Pediatr Hematol Oncol. 2018 Feb 9, 2018;40(3):e159-e163→. doi: 10.1097/MPH.0000000000001095→. PMID: 29432312→. Observational study. ˍ

Łastowska M, Trubicka J, Niemira M, Paczkowska-Abdulsalam M, Karkucińska-Więckowska A, Kaleta M, Drogosiewicz M, Perek-Polnik M, Krętowski A, Cukrowska B, Grajkowska W, Dembowska-Bagińska B, Matyja E.
Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
J Neurooncol. 2018 Feb 9, 2018;138(2):231-240→. doi: 10.1007/s11060-018-2797-5→. PMID: 29427151→. Observational study. ˍ

Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, White CL 3rd, Foong C, Mickey BE, Pan E, Hatanpaa KJ.
Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
J Neuropathol Exp Neurol. 2018 Feb 10, 2018;77(4):302-311→. doi: 10.1093/jnen/nly006→. PMID: 29444279→. Observational study. ˍ

*

André-Grégoire G, Bidère N, Gavard J.
Temozolomide affects Extracellular Vesicles Released by Glioblastoma Cells.
Biochimie. 2018 Feb 15, 2018;155:11-15→. doi: 10.1016/j.biochi.2018.02.007→. PMID: 29454008→. Laboratory investigation. ˍ

Combs SE, Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, Gempt J, Meyer B.
Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability.
Neurosurgery. 2018 Feb 16, 2018;83(6):1241-1248[No available link]. doi: 10.1093/neuros/nyx629? PMID: 29462372→. Observational study. ˍ

Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K, Manno A, Kuzan-Fischer C, Nor C, Donovan LK, Liu J, Qin L, Garancher A, Liu KW, Mansouri S, Luu B, Thompson YY, Ramaswamy V, Peacock J, Farooq H, Skowron P, Shih DJH, Li A, Ensan S, Robbins CS, Cybulsky M, Mitra S, Ma Y, Moore R, Mungall A, Cho YJ, Weiss WA, Chan JA, Hawkins CE, Massimino M, Jabado N, Zapotocky M, Sumerauer D, Bouffet E, Dirks P, Tabori U, Sorensen PHB, Brastianos PK, Aldape K, Jones SJM, Marra MA, Woodgett JR, Wechsler-Reya RJ, Fults DW, Taylor MD.
A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.
Cell. 2018 Feb 22, 2018;172(5):1050-1062.e14→. doi: 10.1016/j.cell.2018.01.038→. PMID: 29474906→. Laboratory investigation. ˍ
Corrected online 2018 Mar 7.

Ferrucci V, de Antonellis P, Pennino FP, Asadzadeh F, Virgilio A, Montanaro D, Galeone A, Boffa I, Pisano I, Scognamiglio I, Navas L, Diana D, Pedone E, Gargiulo S, Gramanzini M, Brunetti A, Danielson L, Carotenuto M, Liguori L, Verrico A, Quaglietta L, Errico ME, Del Monaco V, D'Argenio V, Tirone F, Mastronuzzi A, Donofrio V, Giangaspero F, Picard D, Remke M, Garzia L, Daniels C, Delattre O, Swartling FJ, Weiss WA, Salvatore F, Fattorusso R, Chesler L, Taylor MD, Cinalli G, Zollo M.
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Brain. 2018 Feb 27, 2018;141(5):1300-1319→. doi: 10.1093/brain/awy039→. PMID: 29490009→. Laboratory investigation. ˍ

Pellegatta S, Savoldo B, Di Ianni N, Corbetta C, Chen Y, Patané M, Sun C, Pollo B, Ferrone S, DiMeco F, Finocchiaro G, Dotti G. Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
Sci Transl Med. 2018 Feb 28. 2018;10(430):eaao2731→. doi: 10.1126/scitranslmed.aao2731→. PMID: 29491184→. Laboratory investigation. ˍ
Erratum for the article: Pellegatta S et al., Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy. Sci Transl Med. 2018 Apr 4, 2018;10(435):eaat6463→. doi: 10.1126/scitranslmed.aat6463→. PMID: 29618563→. Correction. ˍ